Ingredients

Gettyimages/Pattadis Walarput

news in brief

Ipca buys API firm Pisgah Labs

By Gareth Macdonald

Ipca Pharmaceutical Inc. has acquired North Carolina drug ingredient firm Pisgah Labs for $9.65m.

Gettyimages/grThirteen

News in brief

Colorcon and Applied DNA Sciences sign tech MOU

By Staff reporter

Colorcon Inc. and Applied DNA Sciences Inc. have teamed up to commercialize an on-dose traceability platform they say will help combat counterfeits.

Gettyimages/wildpixe

update - CEO: ideal model is two to four API plants and six to eight drug facilities

Teva confirms plan to reduce workforce by 14,000 to save $3bn

By Gareth Macdonald

Teva Pharmaceutical Industries will reduce its workforce by 14,000, rejig its generics portfolio and speed up optimization of its plant network as part of a $3bn (€2.5bn) cost saving plan.

GettyImages/Enrique Ramos Lopez

Avista doubles API capacity in Colorado

By Dan Stanton

Avista Pharma has added a fourth GMP suite at its Longmont facility as part of an investment of more than $20m in its manufacturing operations.

US FDA bans APIs made by Fleming Labs

news in brief

US FDA bans APIs made by Fleming Labs

By Gareth Macdonald

Fleming Laboratories has been banned from shipping APIs to the US by the FDA which says its manufacturing plant in Nawabpet, Telangana in India is not up to code.

Follow us

Products

View more

Webinars